|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3122742 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15720269.8 |
| Date of filing the European patent application | 2015-03-26 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (86) | Number | PCT/EP2015/056507 |
| Date | 2015-03-26 |
| (87) | Number | WO 2015/144803 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| 14161820 | 2014-03-26 | EP |
| (72) |
VERMEULEN, Wim, BE
HOSTYN, Steven Anna, BE
CUYCKENS, Filip Albert Celine, BE
JONES, Russell Mark, CH
BROGGINI, Diego Fernando Domenico, CH
|
| (73) |
Astex Therapeutics Ltd,
436 Cambridge Science Park, Milton Road,, Cambridge Cambridgeshire CB4 0QA,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Chinoksalino dariniai, tinkami panaudoti kaip FGFR kinazės moduliatoriai |
| QUINOXALINE DERIVATIVES USEFUL AS FGFR KINASE MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2026-03-06 | 12 | 289.00 EUR |
| 2027-03-26 |